Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Indivior Pharmaceuticals Inc. Common Stock (INDV) vs Pan American Silver Corp. Common Stock (PAAS) Price & Performance

Indivior Pharmaceuticals Inc. Common StockTrade
Pan American Silver Corp. Common StockTrade

Price performance (Past 24H)

Key statistics

Indivior Pharmaceuticals Inc. Common Stock vs Pan American Silver Corp. Common Stock — how do they compare? Indivior Pharmaceuticals Inc. Common Stock trades at $34.3 (market cap $4.18B), while Pan American Silver Corp. Common Stock trades at $42.93 (market cap $18.39B). The key difference: Pan American Silver Corp. Common Stock is far larger — about 4.4× Indivior Pharmaceuticals Inc. Common Stock's market cap, and Pan American Silver Corp. Common Stock pays a 1.65% dividend while Indivior Pharmaceuticals Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indivior Pharmaceuticals Inc. Common Stock for 0 Days and Pan American Silver Corp. Common Stock for 2 Days on average.

INDVPAAS
Market Cap
$4.18B$18.39B
Volume
1,819,7463,168,808
Sector
HealthBasic Materials
52-Week High
$41.83$68.70
52-Week Low
$24.09$33.20
Typical Hold Time
0 Days2 Days
Enterprise Value
$4.47B$17.52B
Dividend Yield
—1.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Indivior Pharmaceuticals Inc. Common Stock

No Aura AI signal available yet.

Pan American Silver Corp. Common Stock

Pan American Silver (PAAS) trades at $44.53, down 2.58% on the day, with a bearish technical signal from moving averages. The company reported strong 2025 results with $978M net income and a 32.03% net margin, and analysts project 2026 revenue growth to $4.3B. Recent news highlights growth from the Timmins and La Colorada projects and a director retirement effective October 31, 2026.

The outlook is positive with a consensus price target of $62.50, implying 40% upside, supported by solid cash flow and reserve growth. Risks include silver price volatility and potential cost pressures. Analyst sentiment is bullish with 52% buy ratings, but technical indicators suggest near-term caution.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

INDV
100% Buy0% Sell
Avg holding period · 0 Days
PAAS
100% Buy0% Sell
Avg holding period · 2 Days

About Indivior Pharmaceuticals Inc. Common Stock

Indivior Pharmaceuticals, Inc. is a pharmaceutical company focused on treatments for opioid use disorder and other addiction-related conditions, including its Suboxone film and tablet products.

Read more on INDV →

About Pan American Silver Corp. Common Stock

Pan American Silver is a mining company focused on silver and gold production in the Americas. It also explores and develops precious metals properties.

Read more on PAAS →